422 related articles for article (PubMed ID: 31171626)
21.
Cho SJ; Yoon C; Lee JH; Chang KK; Lin JX; Kim YH; Kook MC; Aksoy BA; Park DJ; Ashktorab H; Smoot DT; Schultz N; Yoon SS
Clin Cancer Res; 2018 Dec; 24(24):6556-6569. PubMed ID: 30108106
[TBL] [Abstract][Full Text] [Related]
22. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.
Mizrak Kaya D; Nogueras-González GM; Harada K; Amlashi FG; Roy-Chowdhuri S; Estrella JS; Das P; Lee JH; Weston B; Bhutani MS; Matamoros A; Thomas I; Lin Q; Badgwell BD; Ajani JA
J Surg Oncol; 2018 Mar; 117(4):678-684. PubMed ID: 29205363
[TBL] [Abstract][Full Text] [Related]
23. Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients.
Zhu C; Yang Q; Xu J; Zhao W; Zhang Z; Xu D; Zhang Y; Zhao E; Zhao G
J Transl Med; 2019 Apr; 17(1):109. PubMed ID: 30944005
[TBL] [Abstract][Full Text] [Related]
24. Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach.
Wei J; Ji K; Zhang Y; Zhang J; Wu X; Ji X; Zhou K; Yang X; Lu H; Wang A; Bu Z
Cell Oncol (Dordr); 2024 Apr; 47(2):677-693. PubMed ID: 37943484
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Reprogramming in Response to Alterations of Mitochondrial DNA and Mitochondrial Dysfunction in Gastric Adenocarcinoma.
Chang TC; Lee HT; Pan SC; Cho SH; Cheng C; Ou LH; Lin CI; Lin CS; Wei YH
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163779
[TBL] [Abstract][Full Text] [Related]
26. Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.
Hescheler DA; Plum PS; Zander T; Quaas A; Korenkov M; Gassa A; Michel M; Bruns CJ; Alakus H
Gastric Cancer; 2020 Jul; 23(4):627-638. PubMed ID: 32107691
[TBL] [Abstract][Full Text] [Related]
27. FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma.
Wang Y; Shi T; Wang X; Hu J; Yu L; Liu Q; Wu N; Liu B; Wei J
J Transl Med; 2021 Sep; 19(1):401. PubMed ID: 34551773
[TBL] [Abstract][Full Text] [Related]
28. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
[TBL] [Abstract][Full Text] [Related]
29. Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.
Röcken C; Amallraja A; Halske C; Opasic L; Traulsen A; Behrens HM; Krüger S; Liu A; Haag J; Egberts JH; Rosenstiel P; Meißner T
Genome Med; 2021 Nov; 13(1):177. PubMed ID: 34749812
[TBL] [Abstract][Full Text] [Related]
30. Exploiting Molecular and Immune Biology of Gastric and Gastroesophageal Adenocarcinomas to Discover Novel Therapeutic Targets.
Elimova E; Song S; Shimodaira Y; Lin Q; Ajani JA
Ann Surg Oncol; 2016 Nov; 23(12):3786-3791. PubMed ID: 27503493
[TBL] [Abstract][Full Text] [Related]
31. [Molecular biology in clinical cancer research: the example of digestive cancers].
Lièvre A; Laurent-Puig P
Rev Epidemiol Sante Publique; 2005 Jun; 53(3):267-82. PubMed ID: 16227914
[TBL] [Abstract][Full Text] [Related]
32. Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.
Maag JLV; Fisher OM; Levert-Mignon A; Kaczorowski DC; Thomas ML; Hussey DJ; Watson DI; Wettstein A; Bobryshev YV; Edwards M; Dinger ME; Lord RV
Mol Cancer Res; 2017 Nov; 15(11):1558-1569. PubMed ID: 28751461
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma.
Mao R; Liu K; Zhao N; Guo P; Wu Y; Wang Z; Liu Y; Zhang T
Aging (Albany NY); 2021 Jul; 13(13):17734-17767. PubMed ID: 34247148
[TBL] [Abstract][Full Text] [Related]
34. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.
Tanaka K; Nishioka J; Kato K; Nakamura A; Mouri T; Miki C; Kusunoki M; Nobori T
Jpn J Cancer Res; 2001 Sep; 92(9):952-8. PubMed ID: 11572763
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma.
Zhou Z; Huang D; Yang S; Liang J; Wang X; Rao Q
Pathol Oncol Res; 2022; 28():1610479. PubMed ID: 35928964
[No Abstract] [Full Text] [Related]
36. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
Chen K; Yang D; Li X; Sun B; Song F; Cao W; Brat DJ; Gao Z; Li H; Liang H; Zhao Y; Zheng H; Li M; Buckner J; Patterson SD; Ye X; Reinhard C; Bhathena A; Joshi D; Mischel PS; Croce CM; Wang YM; Raghavakaimal S; Li H; Lu X; Pan Y; Chang H; Ba S; Luo L; Cavenee WK; Zhang W; Hao X
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1107-12. PubMed ID: 25583476
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
38. High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.
Labots M; Buffart TE; Haan JC; van Grieken NC; Tijssen M; van de Velde CJ; Grabsch HI; Ylstra B; Carvalho B; Fijneman RJ; Verheul HM; Meijer GA
Cell Oncol (Dordr); 2014 Feb; 37(1):41-52. PubMed ID: 24379144
[TBL] [Abstract][Full Text] [Related]
39. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
van Beek EJAH; Hernandez JM; Goldman DA; Davis JL; McLaughlin K; Ripley RT; Kim TS; Tang LH; Hechtman JF; Zheng J; Capanu M; Schultz N; Hyman DM; Ladanyi M; Berger MF; Solit DB; Janjigian YY; Strong VE
Ann Surg Oncol; 2018 Jul; 25(7):2027-2033. PubMed ID: 29725898
[TBL] [Abstract][Full Text] [Related]
40. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J
J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
